Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders

Acetylcholinesterase inhibitors (AChEI) such as donepezil act in mild Alzheimer's disease (AD) by increasing cholinergic tone. Differences in the clinical response in patients who do or do not benefit from therapy may be due to different functional features of the central neural systems. We tested this hypothesis using cortical electroencephalographic (EEG) rhythmicity. Resting eyes-closed EEG data were recorded in 58 mild AD patients (Mini Mental State Examination [MMSE] range 17-24) before and approximately 1 year after standard donepezil treatment. Based on changes of MMSE scores between baseline and follow-up, 28 patients were classified as "Responders" (MMSEvar >or=0) and 30 patients as "Non-Responders" (MMSEvar <0). EEG rhythms of interest were delta (2-4 Hz), theta (4-8 Hz), alpha 1 (8-10.5 Hz), alpha 2 (10.5-13 Hz), beta 1 (13-20 Hz), and beta 2 (20-30 Hz). Cortical EEG sources were studied with low-resolution brain electromagnetic tomography (LORETA). Before treatment, posterior sources of delta, alpha 1 and alpha 2 frequencies were greater in amplitude in Non-Responders. After treatment, a lesser magnitude reduction of occipital and temporal alpha 1 sources characterized Responders. These results suggest that Responders and Non-Responders had different EEG cortical rhythms. Donepezil could act by reactivating existing yet functionally silent cortical synapses in Responders, restoring temporal and occipital alpha rhythms.

[1]  K. Gulya,et al.  The cholinergic system in Alzheimer's disease , 1997, Progress in Neurobiology.

[2]  Cees Jonker,et al.  Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment , 1999, Journal of Neurology.

[3]  TATSUYA KANAI,et al.  Mesencephalic Reticular Activating System and Cortical Acetylcholine Output , 1965, Nature.

[4]  G Mariani,et al.  99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  M. Steriade.  The corticothalamic system in sleep. , 2003, Frontiers in bioscience : a journal and virtual library.

[6]  H. Fibiger,et al.  Organization of central cholinergic systems. , 1989, Progress in brain research.

[7]  Lo J. Bour,et al.  Spectral analysis of the EEG and 99m-Tc-HMPAO SPECT-scan in Alzheimer's disease , 1993, Biological Psychiatry.

[8]  P. Vitali,et al.  Quantitative EEG Changes in Alzheimer Patients during Long-Term Donepezil Therapy , 2002, Neuropsychobiology.

[9]  R D Pascual-Marqui,et al.  EEG topography and tomography in diagnosis and treatment of mental disorders: evidence for a key-lock principle. , 2002, Methods and findings in experimental and clinical pharmacology.

[10]  Vesna Jelic,et al.  A critical discussion of the role of neuroimaging in mild cognitive impairment * , 2003, Acta neurologica Scandinavica. Supplementum.

[11]  Oscar U. Scremin,et al.  Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin , 1999, Experimental Brain Research.

[12]  Alberto Fernández,et al.  Correlations of hippocampal atrophy and focal low-frequency magnetic activity in Alzheimer disease: volumetric MR imaging-magnetoencephalographic study. , 2003, AJNR. American journal of neuroradiology.

[13]  I Kanno,et al.  Regional correlations between the EEG and oxygen metabolism in dementia of Alzheimer's type. , 1997, Electroencephalography and clinical neurophysiology.

[14]  H. Beppu,et al.  Donepezil for mild and moderate Alzheimer's disease. , 2000 .

[15]  A. Levey,et al.  Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey , 1983, The Journal of comparative neurology.

[16]  R. Reeves,et al.  The Effects of Donepezil on Quantitative EEG in Patients with Alzheimer's Disease , 2002, Clinical EEG.

[17]  Nathan Herrmann,et al.  Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[18]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[19]  A. Korczyn,et al.  EEG changes during long-term treatment with donepezil in Alzheimer's disease patients , 2001, Journal of Neural Transmission.

[20]  Roberto D. Pascual-Marqui,et al.  Electrical Sources of P300 Event-Related Brain Potentials Revealed by Low Resolution Electromagnetic Tomography , 1997, Neuropsychobiology.

[21]  M. Onofrj,et al.  The Effects of a Cholinesterase Inhibitor Are Prominent in Patients With Fluctuating Cognition: A Part 3 Study of the Main Mechanism of Cholinesterase Inhibitors in Dementia , 2003, Clinical neuropharmacology.

[22]  R J Harvey,et al.  Donepezil for dementia due to Alzheimer's disease. , 2006, The Cochrane database of systematic reviews.

[23]  P. M. Rossini,et al.  Brain excitability and electroencephalographic activation: non-invasive evaluation in healthy humans via transcranial magnetic stimulation , 1991, Brain Research.

[24]  Martin Farlow,et al.  A Clinical Overview of Cholinesterase Inhibitors in Alzheimer's Disease , 2002, International Psychogeriatrics.

[25]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[26]  H. Semlitsch,et al.  Non-invasive localization of P300 sources in normal aging and age-associated memory impairment , 2003, Neurobiology of Aging.

[27]  K. Goa,et al.  Galantamine , 2000, Drugs.

[28]  D. Mash,et al.  Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. , 1985, Science.

[29]  Paolo Vitali,et al.  EEG spectral profile to stage Alzheimer's disease , 1999, Clinical Neurophysiology.

[30]  D. Contreras,et al.  Cortical and thalamic cellular correlates of electroencephalographic burst-suppression. , 1994, Electroencephalography and clinical neurophysiology.

[31]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[32]  R. Mayeux,et al.  Treatment of Alzheimer's disease. , 1999, The New England journal of medicine.

[33]  R. Llinás,et al.  The functional states of the thalamus and the associated neuronal interplay. , 1988, Physiological reviews.

[34]  P. Valdés,et al.  A global scale factor in brain topography. , 1994, The International journal of neuroscience.

[35]  Howard Fillit,et al.  PHARMACOLOGIC TREATMENT OF ALZHEIMER'S DISEASE: EFFICACY, DOSING, AND CONTROVERSIES , 2007 .

[36]  M. Mesulam,et al.  Cholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum , 2004, Annals of neurology.

[37]  S. Brassen,et al.  Short-term Effects of Acetylcholinesterase Inhibitor Treatment on EEG and Memory Performance in Alzheimer Patients: an Open, Controlled Trial , 2003, Pharmacopsychiatry.

[38]  Thomas Dierks,et al.  Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease , 2000, Clinical Neurophysiology.

[39]  Claudio Babiloni,et al.  Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric Electroencephalogram study , 2006, Annals of neurology.

[40]  A. Leuchter,et al.  Synaptic dysfunction in Alzheimer's disease: clinical assessment using quantitative EEG , 1996, Behavioural Brain Research.

[41]  F Cincotti,et al.  EEG Deblurring Techniques in a Clinical Context , 2004, Methods of Information in Medicine.

[43]  H Sattel,et al.  Discrimination of Alzheimer's disease and normal aging by EEG data. , 1997, Electroencephalography and clinical neurophysiology.

[44]  D. Geldmacher,et al.  Donepezil Is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease , 2003, Journal of the American Geriatrics Society.

[45]  W. J. Jackson,et al.  Lesions of nucleus basalis alter ChAT activity and EEG in rat frontal neocortex. , 1991, Electroencephalography and clinical neurophysiology.

[46]  Hojjat Adeli,et al.  Alzheimer's Disease: Models of Computation and Analysis of EEGs , 2005, Clinical EEG and neuroscience.

[47]  P. Rossini,et al.  Sources of cortical rhythms in adults during physiological aging: A multicentric EEG study , 2006, Human brain mapping.

[48]  Thomas Dierks,et al.  Dementia of the alzheimer type: Effects on the spontaneous EEG described by dipole sources , 1993, Psychiatry Research: Neuroimaging.

[49]  Roy W Jones,et al.  Have cholinergic therapies reached their clinical boundary in Alzheimer's disease? , 2003, International journal of geriatric psychiatry.

[50]  F Babiloni,et al.  Computerized processing of EEG-EOG-EMG artifacts for multi-centric studies in EEG oscillations and event-related potentials. , 2003, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[51]  Claudio Del Percio,et al.  Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study , 2004, NeuroImage.

[52]  Claudio Del Percio,et al.  Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: A multicentric study , 2006, NeuroImage.

[53]  M. Primeau,et al.  Quantitative Electroencephalography in Frontotemporal Dementia with Methylphenidate Response: A Case Study , 2004, Clinical EEG and neuroscience.

[54]  F. L. D. Silva,et al.  Event-related EEG/MEG synchronization and desynchronization: basic principles , 1999, Clinical Neurophysiology.

[55]  Gastone G. Celesia,et al.  Acetylcholine released from cerebral cortex in relation to state of activation , 1966, Neurology.

[56]  M. Albert,et al.  Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease. , 1993, Archives of neurology.

[57]  P Julin,et al.  Clinical diagnosis of frontal lobe dementia and Alzheimer's disease: relation to cerebral perfusion, brain atrophy and electroencephalography. , 1995, Dementia.

[58]  David M Treiman,et al.  Effects of Cholinergic Deafferentation and NGF on Brain Electrical Coherence , 1998, Brain Research Bulletin.

[59]  Claudio Del Percio,et al.  Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multicenter study , 2006, Clinical Neurophysiology.

[60]  C. L. Cox,et al.  Cellular bases of neocortical activation: modulation of neural oscillations by the nucleus basalis and endogenous acetylcholine , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[61]  Walter G. Sannita,et al.  Cholinergic modulation, visual function and Alzheimer's dementia , 1997, Vision Research.

[62]  Lars-Olof Wahlund,et al.  Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment , 2002, BMC neurology.

[63]  P. Vitali,et al.  Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease , 2004, Clinical Neurophysiology.

[64]  C. Geula,et al.  Cortical cholinergic fibers in aging and Alzheimer's disease: A morphometric study , 1989, Neuroscience.

[65]  R. Mayeux,et al.  Long‐term administration of oral physostigmine in Alzheimer's disease , 1988, Neurology.

[66]  S Tanada,et al.  Brain Acetylcholinesterase Activity in Alzheimer Disease Measured by Positron Emission Tomography , 2000, Alzheimer disease and associated disorders.

[67]  R D Pascual-Marqui,et al.  Differential effects of normal aging on sources of standard N1, target N1 and target P300 auditory event-related brain potentials revealed by low resolution electromagnetic tomography (LORETA). , 1998, Electroencephalography and clinical neurophysiology.

[68]  Soichiro Shimizu,et al.  Cerebral microbleeds in Alzheimer’s disease , 2003, Journal of Neurology.

[69]  K. Herholz,et al.  Quantitative EEG mapping and PET in Alzheimer's disease , 1992, Journal of the Neurological Sciences.

[70]  D O Walter,et al.  Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. , 1993, Electroencephalography and clinical neurophysiology.

[71]  N. Relkin,et al.  A Large, Community-Based, Open-Label Trial of Donepezil in the Treatment of Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[72]  E P Sloan,et al.  Electroencephalography and single photon emission computed tomography in dementia: a comparative study , 1995, Psychological Medicine.

[73]  S. Brassen,et al.  Prediction of treatment response to rivastigmine in Alzheimer’s dementia , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[74]  Stefanie Brassen,et al.  Short-Term Rivastigmine Treatment Reduces EEG Slow-Wave Power in Alzheimer Patients , 2001, Neuropsychobiology.

[75]  M. Trabucchi,et al.  Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors. , 2003, Current medical research and opinion.

[76]  Martin R. Farlow,et al.  A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group. , 1992, JAMA.

[77]  Osborne Rt,et al.  Variations in graduate record examination performance by age and sex. , 1954 .

[78]  W. Pryse-Phillips,et al.  Do we have drugs for dementia? No. , 1999, Archives of neurology.

[79]  Hirofumi Sakurai,et al.  Atrophy of the Substantia innominata on Magnetic Resonance Imaging Predicts Response to Donepezil Treatment in Alzheimer’s Disease Patients , 2003, Dementia and Geriatric Cognitive Disorders.

[80]  G. A. Howell,et al.  Cholinergic denervation-induced increase of chelatable zinc in mossy-fiber region of the hippocampal formation , 1984, Brain Research.

[81]  M. Mesulam.  The cholinergic lesion of Alzheimer's disease: pivotal factor or side show? , 2004, Learning & memory.

[82]  H.-J. Möller,et al.  The Effects of Donepezil in Alzheimer’s Disease – Results from a Multinational Trial1 , 1999, Dementia and Geriatric Cognitive Disorders.

[83]  A. Kling,et al.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. , 1986, The New England journal of medicine.

[84]  K. Bost,et al.  An examination of a possible cortical cholinergic link in the EEG arousal reaction. , 1968, Progress in brain research.

[85]  W. Klimesch.  EEG alpha and theta oscillations reflect cognitive and memory performance: a review and analysis , 1999, Brain Research Reviews.

[86]  F. Angeleri,et al.  EEG power spectrum differences in early and late onset forms of Alzheimer's disease , 1999, Clinical Neurophysiology.

[87]  Vincent W DeLaGarza,et al.  Genetic Predisposition and Environmental Pharmacologic Treatment of Alzheimer's Disease: an Update Clinical Pharmacology , 2022 .

[88]  Kimihiko Abe,et al.  Regional Cerebral Blood Flow Patterns and Response to Donepezil Treatment in Patients with Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[89]  Y. Oda,et al.  The distribution of cholinergic neurons in the human central nervous system. , 2000, Histology and histopathology.

[90]  M R Nuwer,et al.  Quantitative EEG: I. Techniques and Problems of Frequency Analysis and Topographic Mapping , 1988, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[91]  C. Brunia.  Neural aspects of anticipatory behavior. , 1999, Acta psychologica.

[92]  A. Kling,et al.  Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer??s type , 1987 .

[93]  Roberto D. Pascual-Marqui,et al.  Electrical Sources of P300 Event-Related Brain Potentials Revealed by Low Resolution Electromagnetic Tomography , 1997, Neuropsychobiology.

[94]  E. Niedermeyer.  Alpha rhythms as physiological and abnormal phenomena. , 1997, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[95]  Claudio Babiloni,et al.  Individual analysis of EEG frequency and band power in mild Alzheimer's disease , 2004, Clinical Neurophysiology.

[96]  G C Muscas,et al.  Correlations of topographical EEG features with clinical severity in mild and moderate dementia of Alzheimer type. , 1997, Neuropsychobiology.

[97]  T Dierks,et al.  Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: a cross-sectional and longitudinal study , 2000, Clinical Neurophysiology.

[98]  J. C. Jimenez,et al.  High resolution quantitative EEG analysis , 2005, Brain Topography.

[99]  R. Katzman.,et al.  Pathological verification of ischemic score in differentiation of dementias , 1980, Annals of neurology.

[100]  G. Buzsáki,et al.  Nucleus basalis and thalamic control of neocortical activity in the freely moving rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[101]  C. Geula,et al.  Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. , 1996, Cerebral cortex.

[102]  N. Battistini,et al.  Quantitative EEG mapping, regional cerebral blood flow, and neuropsychological function in Alzheimer's disease. , 1995, Dementia.

[103]  P. Pasqualetti,et al.  Alpha rhythms in mild dements during visual delayed choice reaction time tasks: A MEG study , 2005, Brain Research Bulletin.

[104]  M. Lawton,et al.  Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily Living , 1969 .

[105]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[106]  O Almkvist,et al.  Quantitative electroencephalography power and coherence in Alzheimer's disease and mild cognitive impairment. , 1996, Dementia.